Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jan 31, 2017 | $16.9B |
| FY2018, ended Jan 31, 2018 | $25.4B |
| FY2019, ended Jan 31, 2019 | $40.3B |
| FY2020, ended Jan 31, 2020 | $42.8B |
| FY2021, ended Jan 31, 2021 | $55.3B |
| FY2022, ended Jan 31, 2022 | $63.5B |
| FY2023, ended Jan 31, 2023 | $47.0B |
| FY2024, ended Jan 31, 2024 | $76.8B |
| FY2025, ended Jan 31, 2025 | $69.7B |
| FY2026, ended Jan 31, 2026 | $45.1B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $38.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jan 31, 2017 | $1.57B |
| FY2018, ended Jan 31, 2018 | $2.14B |
| FY2019, ended Jan 31, 2019 | $2.82B |
| FY2020, ended Jan 31, 2020 | $3.63B |
| FY2021, ended Jan 31, 2021 | $4.32B |
| FY2022, ended Jan 31, 2022 | $5.14B |
| FY2023, ended Jan 31, 2023 | $6.22B |
| FY2024, ended Jan 31, 2024 | $7.26B |
| FY2025, ended Jan 31, 2025 | $8.45B |
| FY2026, ended Jan 31, 2026 | $9.55B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $10.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jan 31, 2017 | −$385M | $230M |
| FY2018, ended Jan 31, 2018 | −$321M | $324M |
| FY2019, ended Jan 31, 2019 | −$418M | $404M |
| FY2020, ended Jan 31, 2020 | −$481M | $621M |
| FY2021, ended Jan 31, 2021 | −$282M | $1.02B |
| FY2022, ended Jan 31, 2022 | $29.0M | $1.39B |
| FY2023, ended Jan 31, 2023 | −$367M | $1.29B |
| FY2024, ended Jan 31, 2024 | $1.38B | $1.92B |
| FY2025, ended Jan 31, 2025 | $526M | $2.19B |
| FY2026, ended Jan 31, 2026 | $693M | $2.78B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $1.25B | $2.84B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jan 31, 2017 | $540M |
| FY2018, ended Jan 31, 2018 | $1.13B |
| FY2019, ended Jan 31, 2019 | $639M |
| FY2020, ended Jan 31, 2020 | $731M |
| FY2021, ended Jan 31, 2021 | $1.38B |
| FY2022, ended Jan 31, 2022 | $1.53B |
| FY2023, ended Jan 31, 2023 | $1.89B |
| FY2024, ended Jan 31, 2024 | $2.01B |
| FY2025, ended Jan 31, 2025 | $1.54B |
| FY2026, ended Jan 31, 2026 | $1.50B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $661M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jan 31, 2017 | $0 |
| FY2018, ended Jan 31, 2018 | $1.49B |
| FY2019, ended Jan 31, 2019 | $1.20B |
| FY2020, ended Jan 31, 2020 | $1.26B |
| FY2021, ended Jan 31, 2021 | $1.80B |
| FY2022, ended Jan 31, 2022 | $1.84B |
| FY2023, ended Jan 31, 2023 | $2.98B |
| FY2024, ended Jan 31, 2024 | $2.98B |
| FY2025, ended Jan 31, 2025 | $2.98B |
| FY2026, ended Jan 31, 2026 | $2.99B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $2.99B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 18.7% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jan 31, 2017 | 203M |
| FY2018, ended Jan 31, 2018 | 212M |
| FY2019, ended Jan 31, 2019 | 222M |
| FY2020, ended Jan 31, 2020 | 232M |
| FY2021, ended Jan 31, 2021 | 243M |
| FY2022, ended Jan 31, 2022 | 251M |
| FY2023, ended Jan 31, 2023 | 259M |
| FY2024, ended Jan 31, 2024 | 264M |
| FY2025, ended Jan 31, 2025 | 266M |
| FY2026, ended Jan 31, 2026 | 257M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 241M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2017, ended Jan 31, 2017 | — | $372M |
| FY2018, ended Jan 31, 2018 | — | $478M |
| FY2019, ended Jan 31, 2019 | — | $652M |
| FY2020, ended Jan 31, 2020 | — | $860M |
| FY2021, ended Jan 31, 2021 | $0 | $1.00B |
| FY2022, ended Jan 31, 2022 | $0 | $1.10B |
| FY2023, ended Jan 31, 2023 | $75.0M | $1.29B |
| FY2024, ended Jan 31, 2024 | $423M | $1.42B |
| FY2025, ended Jan 31, 2025 | $700M | $1.52B |
| FY2026, ended Jan 31, 2026 | $2.90B | $1.63B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $5.23B | $1.65B |
Valuation
At current price- Market Cap
- $49.5B
- P/E
- 39.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.9×
- Price / Book
- 7.7×
- EV / EBITDA
- 39.5×
Growth
Trailing 12 months- Revenue (TTM)
- $10.2B
- Revenue Growth YoY
- 13.3%
- Revenue CAGR 3Y
- 15.4%
- Revenue CAGR 5Y
- 17.2%
- EPS Growth YoY
- 128%
- Net Income Growth YoY
- 115%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 10.7%
- Net Margin
- 12.3%
- FCF Margin
- 28.0%
- Return on Equity
- 16.0%
Earnings
Trailing 12 months- Net Income
- $1.25B
- EPS (diluted)
- $4.91
- EBITDA
- $1.31B
- Operating Income
- $1.08B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $661M
- Total Debt
- $2.99B
- Net Debt
- $2.33B
- Total Assets
- $15.9B
- Total Liabilities
- $9.40B
- Shareholders' Equity
- $6.46B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.08B
- Capital Expenditure
- $237M
- Free Cash Flow
- $2.84B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.07
Every ratio is calculated from the company’s reported figures.